Dublin, May 28, 2018 (GLOBE NEWSWIRE) — The “Microfluidics – A Global Market Overview” report has been added to ResearchAndMarkets.com’s offering.
Point of Care (PoC) Diagnostics is projected the fastest growing application area of microfluidics with a CAGR of 19.2% and is also estimated the largest consumer of microfluidics estimated at US$1.6 billion in 2017 and expected to touch US$4.5 billion in 2023.
Microfluidics can be described as the manipulation and analysis of minute volumes of fluid and has evolved over the past three decades into a powerful technology with a number of established and relevant applications within the biological sciences. The research and development conducted over the years in this unique technology has yielded an abundance of techniques that enhance biological assays through the miniaturization of existing methods, in addition to developing innovative analytical approaches.
[…}
3. KEY GLOBAL PLAYERS
Leukapheresis is a critical treatment for children with symptomatic hyperleukocytosis, a condition where extremely high…
Despite the significant advancements brought by immune checkpoint inhibitors (ICIs) in melanoma treatment, patient responses…
Traditional developmental toxicity (DevTox) studies largely rely on mammalian models to assess chemical impacts on…
Circulating tumor cells (CTCs) hold the potential for cancer diagnosis and monitoring, offering a non-invasive…
Leukocyte differentiation and counting are critical for clinical diagnostics but are hindered by the low…
Screening for microbial proteolytic activity is essential in various biotechnological applications, including bioenergy, food processing,…